• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成组序贯II期临床试验后样本比例的偏倚

The bias of the sample proportion following a group sequential phase II clinical trial.

作者信息

Chang M N, Wieand H S, Chang V T

机构信息

Department of Statistics, University of Florida, Gainesville 32611.

出版信息

Stat Med. 1989 May;8(5):563-70. doi: 10.1002/sim.4780080505.

DOI:10.1002/sim.4780080505
PMID:2727475
Abstract

Group sequential testing procedures have seen wide use in Phase II clinical trials. The sample proportion p of responders is the commonly used estimator for the binomial response probability p. It can be shown that p is the maximum likelihood estimator (MLE) of p. It is well known that MLE can be in general (Whitehead) and p in particular (Dupont) biased estimators, if ther computation follows a group sequential procedure. In this paper we numerically investigate the bias of p. We find that the magnitude of the bias of p is less than 0.025 in all cases we investigated. We apply the idea in Whitehead to propose a bias-adjusted estimator that reduces the bias substantially and reduces the mean square error as well in a certain range of p. We also evaluate the uniformly minimum variance unbiased (UMVU) estimator. If one does not mind a bias of 0.025, one may find the sample proportion a suitable estimator for p because of its simplicity and easy explanation. If one is concerned with bias, the bias-adjusted estimator may be a good choice.

摘要

序贯检验程序在II期临床试验中得到了广泛应用。响应者的样本比例p是二项式响应概率p常用的估计量。可以证明,p是p的最大似然估计量(MLE)。众所周知,如果计算遵循序贯检验程序,MLE一般(怀特黑德)尤其是p(杜邦)可能是有偏估计量。在本文中,我们对p的偏差进行了数值研究。我们发现在我们研究的所有情况下,p的偏差幅度均小于0.025。我们应用怀特黑德的思想提出了一种偏差调整估计量,该估计量在一定的p范围内能大幅减少偏差并降低均方误差。我们还评估了一致最小方差无偏(UMVU)估计量。如果不介意0.025的偏差,由于样本比例简单且易于解释,人们可能会发现它是p的合适估计量。如果关注偏差,偏差调整估计量可能是个不错的选择。

相似文献

1
The bias of the sample proportion following a group sequential phase II clinical trial.成组序贯II期临床试验后样本比例的偏倚
Stat Med. 1989 May;8(5):563-70. doi: 10.1002/sim.4780080505.
2
A simple and efficient bias-reduced estimator of response probability following a group sequential phase II trial.一种用于成组序贯II期试验后反应概率的简单有效且偏差减小的估计量。
J Biopharm Stat. 2005;15(5):773-81. doi: 10.1081/BIP-200067771.
3
On the estimation of the binomial probability in multistage clinical trials.关于多阶段临床试验中二元概率的估计
Stat Med. 2004 Mar 30;23(6):881-96. doi: 10.1002/sim.1653.
4
Estimation of the log-normal mean.对数正态均值的估计。
Stat Med. 1998 Oct 15;17(19):2251-64. doi: 10.1002/(sici)1097-0258(19981015)17:19<2251::aid-sim925>3.0.co;2-w.
5
Supplementary analysis of probabilities at the termination of a group sequential phase II trial.成组序贯II期试验结束时概率的补充分析。
Stat Med. 2005 Apr 15;24(7):1009-27. doi: 10.1002/sim.1990.
6
Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival data.具有生存数据的临床试验中期分析中条件偏差调整估计量的比较。
Stat Med. 2017 Jun 15;36(13):2067-2080. doi: 10.1002/sim.7258. Epub 2017 Feb 17.
7
Point estimation following a two-stage group sequential trial.两阶段分组序贯试验后的点估计。
Stat Methods Med Res. 2023 Feb;32(2):287-304. doi: 10.1177/09622802221137745. Epub 2022 Nov 16.
8
Conditional estimation using prior information in 2-stage group sequential designs assuming asymptotic normality when the trial terminated early.在两阶段成组序贯设计中,当试验提前终止时,在假设渐近正态性的情况下使用先验信息进行条件估计。
Pharm Stat. 2018 Sep;17(5):400-413. doi: 10.1002/pst.1859. Epub 2018 Apr 23.
9
A comparison of estimation methods adjusting for selection bias in adaptive enrichment designs with time-to-event endpoints.比较时间事件终点适应性富集设计中调整选择偏差的估计方法。
Stat Med. 2022 May 10;41(10):1767-1779. doi: 10.1002/sim.9327. Epub 2022 Jan 31.
10
Reduction of bias in estimating the frequency of recessive genes.减少隐性基因频率估计中的偏差。
Am J Hum Genet. 1980 Mar;32(2):212-22.

引用本文的文献

1
Statistical Inference for a Two-Stage Adaptive Seamless Design Using Different Binary Endpoints.使用不同二元终点的两阶段自适应无缝设计的统计推断
Stat Med. 2025 Mar 15;44(6):e70003. doi: 10.1002/sim.70003.
2
Practical and analytical considerations when performing interim analyses in diagnostic test accuracy studies.在诊断试验准确性研究中进行期中分析时的实际与分析考量。
Diagn Progn Res. 2024 Aug 20;8(1):12. doi: 10.1186/s41512-024-00174-4.
3
Point estimation for adaptive trial designs I: A methodological review.自适应试验设计的点估计 I:方法学综述。
Stat Med. 2023 Jan 30;42(2):122-145. doi: 10.1002/sim.9605. Epub 2022 Nov 30.
4
Sources of bias for single-arm phase II cancer clinical trials.单臂II期癌症临床试验的偏倚来源。
Ann Transl Med. 2022 Sep;10(18):1037. doi: 10.21037/atm-21-6808.
5
A stochastically curtailed single-arm phase II trial design for binary outcomes.针对二分类结局的随机截尾单臂二期临床试验设计。
J Biopharm Stat. 2022 Sep 3;32(5):671-691. doi: 10.1080/10543406.2021.2009498. Epub 2022 Jan 25.
6
A stochastically curtailed two-arm randomised phase II trial design for binary outcomes.一种用于二分类结局的随机截尾两臂Ⅱ期临床试验设计。
Pharm Stat. 2021 Mar;20(2):212-228. doi: 10.1002/pst.2067. Epub 2020 Aug 29.
7
Statistical inference for extended or shortened phase II studies based on Simon's two-stage designs.基于西蒙两阶段设计的扩展或缩短的II期研究的统计推断。
BMC Med Res Methodol. 2015 Jun 7;15:48. doi: 10.1186/s12874-015-0039-5.
8
What inference for two-stage phase II trials?两阶段 II 期临床试验的推断是什么?
BMC Med Res Methodol. 2012 Aug 6;12:117. doi: 10.1186/1471-2288-12-117.
9
A Bayesian approach for unplanned sample sizes in phase II cancer clinical trials.用于 II 期癌症临床试验中未计划样本量的贝叶斯方法。
Clin Trials. 2012 Jun;9(3):293-302. doi: 10.1177/1740774512443429. Epub 2012 Apr 20.
10
Proper inference from Simon's two-stage designs.从西蒙两阶段设计中进行正确推断。
Stat Med. 2008 Jul 20;27(16):3145-54. doi: 10.1002/sim.3123.